Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02554968 · ClinicalTrials.gov registry record
Reliability and Validity of Patient Reported Outcome Measures in Head and Neck Cancer
A clinical trial of Head and Neck Cancer and Shoulder Pain, sponsored by Mayo Clinic.
- Completed
- Registry status
- 182
- Enrollment target
- 3
- Study locations
NCT02554968: Completed study of Head and Neck Cancer and Shoulder Pain, sponsored by Mayo Clinic.
NCT02554968 is a study of Head and Neck Cancer and Shoulder Pain that has completed, run by Mayo Clinic. The registered enrollment target is 182 participants, below the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (30% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02554968, a study of Head and Neck Cancer and Shoulder Pain, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 182 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study will utilize Rasch analysis to study the construct validity and reliability of five shoulder-related patient-reported outcome measures in patients reporting shoulder impairment following surgery for head and neck cancer.
Conditions Studied
Interventions
- OTHER Questionnaires
Study Locations (3)
Arizona
- Mayo Clinic - Phoenix
Florida
- Mayo Clinic - Jacksonville
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2015-09 |
| Est. Completion | 2017-09 |
What the finished NCT02554968 record still lists
NCT02554968 is an observational study that tracks outcomes without assigning an intervention. The registered 182 participants enrollment target is mid-sized for trials with a published cap, below the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (30% lower).
The record links to 2 conditions, with Head and Neck Cancer appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires is the first listed.
NCT02554968 reports a single indexed study location in Arizona, Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT02554968 about?
NCT02554968 is a clinical study titled "Reliability and Validity of Patient Reported Outcome Measures in Head and Neck Cancer". This study will utilize Rasch analysis to study the construct validity and reliability of five shoulder-related patient-reported outcome measures in patients reporting shoulder impairment following surgery for head and neck cancer.
What is the current status of trial NCT02554968?
This trial is currently completed. The enrollment target is 182 participants. The study started on 2015-09. Estimated completion is 2017-09.
What conditions does trial NCT02554968 study?
This clinical trial studies the following conditions: Head and Neck Cancer, Shoulder Pain.
What interventions are being tested in trial NCT02554968?
The interventions under investigation include: Questionnaires (OTHER).
Who is sponsoring clinical trial NCT02554968?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02554968 being conducted?
This trial has 3 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02554968's enrollment target sits among peer trials
182 52nd of 250 higher than 199 of 250 other Head and Neck Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Head and Neck Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
3D Specimen Maps for RT Planning
RECRUITING
-
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
RECRUITING · Phase 1
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck
RECRUITING · NA
-
RAPA-201 Therapy of Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- NCT04323735 · 182 participants · Phase 2
Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters
- NCT05606731 · 182 participants · NA
Family Intervention to Prevent Childhood Obesity
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia